•  
      Bringing together families affected by neuroblastoma from across the globe 
      with those who work to treat, help, and support them.

       

    • 2021 NPGS Sessions On-Demand

      Catch up on any sessions you missed!

    • 2020 NPGS Sessions On-Demand

    •  

      Neuroblastoma Parent Global Symposium

      5th & 6th November 2021

       

      Bringing together families affected by neuroblastoma from across the globe with those who work to treat, help, and support them.
       
      Hosted online over two days, this FREE virtual event provides valuable content for families, neuroblastoma survivors, researchers, clinicians and other healthcare professionals, as well as charitable organisations.
       
      The event programme includes live and pre-recorded sessions, with presentations from internationally renowned experts, specialised conversation rooms and parent-driven Q&A. Live sessions were recorded and are available for on-demand viewing through the links above. Session topics included:
      • Information for newly diagnosed families
      • Overview of international clinical trial landscape
      • Drug development and emerging research
      • Supportive care management
      • Survivorship issues
         

    • Outstanding Initiative

      "Thank you for the opportunity to contribute to this outstanding initiative. It was beneficial to learn from my colleagues who work in areas outside of my expertise – it was refreshing to attend such diverse talks that were communicated so well."

      Christina Signorelli,
      Kids Cancer Center Sydney
      2020 NPGS Speaker

      Amazing Experts

      "This event highlighted how well connected the pediatric oncology world is. We are fortunate to have so many amazing experts around the globe searching for better treatments and cures for this devastating disease. Thank you for organising!"

      Adam, Australia
      2020 NPGS Attendee

      Phenomenal Resource

      “What a phenomenal resource for families to connect, share information, and build a global community!

      Thank you for making this possible for families all over the world!”

       

      Jessica, United States
      2020 NPGS Attendee

    • THE ORGANISERS

      Solving Kids’ Cancer UK is a parent-led charity, our vision is a future where no child dies of neuroblastoma or suffers due to its treatment. We provide emotional and practical support to families and our research focus is on clinical trials, seeking to explore new ways of treating neuroblastoma, providing hope and options for children and their families now and in the future. www.solvingkidscancer.org.uk
       
      Solving Kids' Cancer UK is a registered charity in England and Wales (1135601), and in Scotland (SCO45094). It is a company limited by guarantee in England and Wales (7208646).

      The Children’s Neuroblastoma Cancer Foundation (CNCF) is the premier source for neuroblastoma information and resources. Comprised of families just like yours, we are committed to finding a cure for neuroblastoma through research, education, awareness and advocacy. Visit www.cncfhope.org/ to find out more about the work of CNCF.
       
      Children's Neuroblastoma Cancer Foundation (CNCF) is recognized as a public charity under Section
      501(c)(3) of the US Internal Revenue Code.
      Federal ID 36-4370725.
       

      Solving Kids’ Cancer is not just our name, it’s our mission. We focus on aggressive childhood cancers with low survival rates—because Every Kid Deserves to Grow Up. Solving Kids' Cancer (SKC) helps accelerate clinical trials of next-generation treatments with an understanding of the global childhood cancer research landscape 

      and current unmet needs. 

      www.solvingkidcancer.org

       

      Solving Kids' Cancer is recognized as a registered public charity under Section 501(c)(3) of the US Internal Revenue Code. Federal ID: 20-8735688.

       

       

       

    © 2021

      Cookie Use
      We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
      Learn More